Meissner Corporation Expands Athens Manufacturing Campus
The company opened a new X-ray irradiation facility and broke ground on Phase 2 of its Georgia operations.
Updated on Oct. 23, 2026 in Openings & Closings
Live Poll
Do you support large-scale manufacturing expansion projects in your local community?
Meissner Corporation has officially opened a new X-ray irradiation facility in Athens, Georgia, and broken ground on the second phase of its manufacturing campus. The project is designed to enhance sterilization capacity and strengthen supply chain resilience for biopharmaceutical customers.
Why it matters
This expansion bolsters regional manufacturing capabilities on the East Coast of the United States while supporting the broader biopharmaceutical industry. The facility provides critical sterilization services for both internal products and third-party clients.
The Athens campus represents a $250 million investment and is expected to create 1,700 jobs in Athens-Clarke County. The facility is located at 520 Meissner Avenue.
The players
Meissner Corporation
The company is a manufacturer of bioprocessing systems and sterilization solutions with headquarters in Camarillo, California.
U.S. Department of Health and Human Services
This federal agency is responsible for protecting the health of all Americans and provided funding for the X-ray irradiation project.
University of Georgia
This public research university in Athens is one of the academic partners involved in the campus expansion project.
Georgia Institute of Technology
This public research university in Atlanta is collaborating with Meissner Corporation on its new manufacturing initiatives.
Athens Technical College
This local technical college is partnering with the company as part of the broader campus workforce development effort.
The details
Supported by funding from the U.S. Department of Health and Human Services, the site includes collaborations with the University of Georgia, the Georgia Institute of Technology, and Athens Technical College. Phase 2 of the project will significantly increase the existing footprint for advanced manufacturing operations.
Timeline
Meissner announced the $250 million Athens campus investment in 2023.
Ribbon cutting and groundbreaking ceremonies were held in October 2026.
Market Landscape
This development marks a significant expansion of East Coast biomanufacturing as Meissner aims to compete with existing production sites in Camarillo, California, and Castlebar, Ireland. The investment signals a broader industry move toward localized production to mitigate global supply chain volatility.
The creation of 1,700 jobs in the Athens-Clarke County area offers new employment opportunities for local residents in engineering, scientific, and IT roles. Prospective applicants can engage with the company's hiring process as the site reaches full operational capacity.
The takeaway
The investment demonstrates how federal funding can catalyze private infrastructure to strengthen domestic medical manufacturing. Residents looking to enter the specialized biopharmaceutical sector may find new career pathways as the campus continues to scale operations.
Further reading
For more information on local industrial growth, view the latest updates on the Athens Openings & Closings.
More information
To explore open positions at the new campus, visit the Meissner corporate careers page.
Source note: This article includes information reported by Pharmaceuticalonline.
Live Poll
Do you support large-scale manufacturing expansion projects in your local community?
